Goldman Sachs Group Inc - Dec 31, 2024 SCHEDULE 13G Report for SYNDAX PHARMACEUTICALS, INC. Common Stock (SNDX)

Filing Manager: GOLDMAN SACHS GROUP INC
Reporting Manager: THE GOLDMAN SACHS GROUP, INC.
Security: SYNDAX PHARMACEUTICALS, INC. Common Stock
Symbol: SNDX
Shares outstanding: 85M shares
Disclosed Ownership: 5.95M shares
Ownership: 7%
Form type: SCHEDULE 13G
Date filed: 2/12/2025, 11:39 AM
Date of event: Dec 31, 2024
Next filing: May 9, 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
THE GOLDMAN SACHS GROUP, INC.	7%	5.95M	0	5.95M	Name: Ameen Soetan	Attorney-in-fact
GOLDMAN SACHS & CO. LLC	7%	5.95M	0	5.95M	Name: Ameen Soetan	Attorney-in-fact